Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Mini oral session: Head and neck cancer

357MO - Comparison of long-term quality of life between survivors of adolescent and adult nasopharyngeal carcinoma

Date

02 Dec 2023

Session

Mini oral session: Head and neck cancer

Topics

Tumour Site

Head and Neck Cancers

Presenters

Liting Liu

Citation

Annals of Oncology (2023) 34 (suppl_4): S1607-S1619. 10.1016/annonc/annonc1385

Authors

J. Jin1, Q.Y. Chen1, L. Liu2, S. Guo1, D.X. Wen1, J.Y. Lin1, J.H. Yang1, R. Li1

Author affiliations

  • 1 Department Of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 510060 - Guangzhou/CN
  • 2 Department Of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 510060 - Guangzhou/CN

Resources

This content is available to ESMO members and event participants.

Abstract 357MO

Background

Nasopharyngeal carcinoma (NPC) is not commonly observed in adolescents. The late sequelae and long-term survival outcomes diverge between adult and adolescent survivors of NPC. This study was to compare the differences between these two cohorts and evaluate the socio-demographic and clinical factors that have the most significant impact on different aspects of quality of life.

Methods

A total of 420 survivors could be included (195 adolescent and 225 adult survivors). To balance the influence of covariates and potential bias, we used the propensity score matching (PSM) method to match adolescent and adult patients at a ratio of 1:1. Ultimately, we included 155 adolescent and 155 adult survivors in the subsequent analysis. The EORTC QLQ-C30 consists of 30 items spread across 15 dimensions, comprising of 5 functional dimensions, 1 dimension measuring Global health status/QoL, and individual symptom items. The functioning and QoL scales are such that a higher score indicates better health, whereas a higher score on the symptom scales indicates a higher severity of symptoms.

Results

In terms of Global health status, adolescent patients had higher scores than those of adult patients (adolescent: 80.2±12.7; adult: 77.2±11.5; P=0.027). Furthermore, there were also differences in the Functional Scale/Items. Adolescent patients scored higher in Physical functioning (adolescent: 98.5±4.6; adult: 95.1±7.0; P<0.001), Role functioning (adolescent: 97.0±9.2; adult: 90.5±15.2; P<0.001),and Social functioning (adolescent: 96.0±9.0; adult: 93.5±11.8; P=0.038) but had worse Cognitive functioning (adolescent: 88.3±9.9; adult: 93.8±12.6; P<0.001) scores than adult patients. There were also differences in the symptom scale/items, including insomnia (adolescent: 1.9±7.8; adult: 13.1±22.3; P<0.001), constipation (adolescent: 1.29±7.5; adult: 8.0±17.4; P<0.001) and diarrhea (adolescent: 0.65±4.6; adult: 2.8±9.2; P=0.010).

Conclusions

We can infer that adolescent NPC patients are a particular group of patients that, compared to adult patients achieve better survival outcomes, and experience less treatment-related long-term toxicity, and a higher quality of life in the long term.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.